Skip to main content

Ignyta Inc (NASDAQ:RXDX) Investor Lawsuit Filed Against Acquisition By Roche

  • If you purchased shares of Ignyta Inc (NASDAQ:RXDX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 9, 2018 - The case was voluntarily dismissed. January 12, 2018 - An investor, who currently holds shares of Ignyta Inc (NASDAQ: filed a lawsuit in effort to halt the proposed takeover of Ignyta Inc by Roche for $27.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:RXDX stockholders by agreeing to sell Ignyta Inc cheaply via...



You must register (for free) or login to view the entire case.